{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:34:16Z","timestamp":1793835256437,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI23C1493"],"award-info":[{"award-number":["HI23C1493"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["2020M3A9E403918422"],"award-info":[{"award-number":["2020M3A9E403918422"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jhepr.2025.101713","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:02:40Z","timestamp":1765958560000},"page":"101713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integration of PNPLA3 and TM6SF2 genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-3385","authenticated-orcid":false,"given":"Dong Yun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4973-9792","authenticated-orcid":false,"given":"Hyun-Soo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-3035","authenticated-orcid":false,"given":"Hyun Woong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon Yung","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Il","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-2224","authenticated-orcid":false,"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101713_bib2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib3","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.jhepr.2025.101713_bib4","doi-asserted-by":"crossref","DOI":"10.3350\/cmh.2022.0431","article-title":"Identification of high-risk subjects in nonalcoholic fatty liver disease","volume":"29","author":"Stern","year":"2023","journal-title":"Clin Mol Hepatol"},{"issue":"17","key":"10.1016\/j.jhepr.2025.101713_bib5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101713_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib7","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101713_bib8","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20132021 update","volume":"75","author":"Panel","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib10","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.jhep.2023.02.029","article-title":"Agile scores are a good predictor of liver-related events in patients with NAFLD","volume":"79","author":"Nakatsuka","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101713_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2022.10.034","article-title":"Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101713_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.101925","article-title":"Comparison of screening strategies with two new tests to score and diagnose varices needing treatment","volume":"46","author":"Cal\u00e8s","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"10.1016\/j.jhepr.2025.101713_bib13","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038322","article-title":"Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese","volume":"7","author":"Kawaguchi","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jhepr.2025.101713_bib15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2025.101713_bib16","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1038\/srep09284","article-title":"Association between patatin-like phospholipase domain containing 3 gene (PNPLA3) polymorphisms and nonalcoholic fatty liver disease: a HuGE review and meta-analysis","volume":"5","author":"Xu","year":"2015","journal-title":"Sci Rep"},{"issue":"85","key":"10.1016\/j.jhepr.2025.101713_bib17","first-page":"10","article-title":"Genetic risk factors associated with NAFLD","volume":"6","author":"Kim","year":"2020","journal-title":"Hepatoma Res"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101713_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1071","article-title":"Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease","volume":"33","author":"Lohmueller","year":"2003","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101713_bib19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41588-024-01720-y","article-title":"Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis","volume":"56","author":"Ghouse","year":"2024","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101713_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.jhepr.2025.101713_bib23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdi.13756","article-title":"Non-alcoholic fatty liver disease and type 2 diabetes: an update","volume":"13","author":"Lee","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib25","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HEP.0000000000000432","article-title":"Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: a landmark analysis","volume":"78","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhepr.2025.101713_bib27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.jhepr.2025.101713_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH\u2014current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101713_bib29","series-title":"Clinical prediction models: a practical approach to development, validation, and updating","author":"Steyerberg","year":"2019"},{"key":"10.1016\/j.jhepr.2025.101713_bib30","series-title":"Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis","author":"Harrell","year":"2015"},{"key":"10.1016\/j.jhepr.2025.101713_bib31","series-title":"The elements of statistical learning: data mining, inference, and prediction","author":"Hastie","year":"2009"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"9","key":"10.1016\/j.jhepr.2025.101713_bib33","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/sim.5727","article-title":"Testing for improvement in prediction model performance","volume":"32","author":"Pepe","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.jhepr.2025.101713_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-11-13","article-title":"One statistical test is sufficient for assessing new predictive markers","volume":"11","author":"Vickers","year":"2011","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101713_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01186-2021","article-title":"Moving beyond AUC: decision curve analysis for quantifying net benefit of risk prediction models","volume":"58","author":"Sadatsafavi","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhepr.2025.101713_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn prognostic Res"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101713_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ijo.2009.216","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"Romeo","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101713_bib38","article-title":"The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat","volume":"6","author":"Giudice","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2023.01.040","article-title":"PNPLA3 genotype and diabetes identify patients with nonalcoholic fatty liver disease at high risk of incident cirrhosis","volume":"164","author":"Chen","year":"2023","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101713_bib41","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000896","article-title":"PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease","volume":"80","author":"Chalasani","year":"2024","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101713_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101713_bib43","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.cgh.2020.02.011","article-title":"Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in Asian patients with nonalcoholic fatty liver disease","volume":"18","author":"Koo","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jhepr.2025.101713_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","volume":"72","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101713_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.04.035","article-title":"High inherited risk predicts age-associated increases in fibrosis in patients with MASLD","author":"D\u00edaz","year":"2025","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhepr.2025.101713_bib47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.cgh.2021.05.056","article-title":"A polygenic risk score to refine risk stratification and prediction for severe liver disease by clinical fibrosis scores","volume":"20","author":"De Vincentis","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10319","key":"10.1016\/j.jhepr.2025.101713_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101713_bib49","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101713_bib50","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101713_bib51","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2020.06.007","article-title":"Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease","volume":"73","author":"Hagstr\u00f6m","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhepr.2025.101713_bib52","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJMc2402341","article-title":"Phase 1 trials of PNPLA3 siRNA in I148M homozygous patients with MAFLD","volume":"391","author":"Fabbrini","year":"2024","journal-title":"N Engl J Med"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925003969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:22:32Z","timestamp":1777634552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925003969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2589555925003969"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101713","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of PNPLA3 and TM6SF2 genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101713"}}